On March 23, 2023, Farallon Capital Management, L.L.C. announced that it has provided written notice to Exelixis, Inc. of its intent to nominate each of Tomas J. Heyman, David E. Johnson, and Robert Oliver for election to the Board at the Companyâs 2023 annual meeting of stockholders. In connection with such notice, Farallon Capital Management has communicated, and expects to continue to communicate, with the Company about Board composition and other matters.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.37 USD | -1.79% | -2.42% | -10.92% |
May. 10 | Exelixis Files Patent Complaint Against Cipla's Cancer Treatment | DJ |
May. 01 | RBC Trims Exelixis' Price Target to $27 From $28, Outperform Rating Kept | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.92% | 6.22B | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Farallon Capital Management Submits a Nomination Notice to Exelixis